Patents Assigned to Topaz Pharmaceuticals Inc.
  • Publication number: 20100093652
    Abstract: A topical formulation that inhibits the growth of microorganisms comprises an effective amount of an insecticide dissolved in an oil phase comprising a water-miscible or water-soluble surface active agent, a suspending agent, and a non-ionic surfactant, and an aqueous phase comprising one or more preservatives, where the aqueous phase is buffered to a specific pH. The overall antimicrobial efficacy in an emulsion formulation can be enhanced by buffering the aqueous phase of the emulsion to a pH at which the preservative system inhibits growth for a wider variety of microorganism types in the formulation relative to the equivalent formulation in which the aqueous phase is not buffered.
    Type: Application
    Filed: October 29, 2009
    Publication date: April 15, 2010
    Applicant: Topaz Pharmaceuticals Inc.
    Inventors: Nicholas Spring, Edward J. Delaney